While there are some case studies of patients experiencing pain after eating when taking a GLP-1, these are rare
Step 4 Comfortable IV Treatment Your provider prepares and administers your IV in a relaxed setting
Its April 15th, 2025, and Im about to do my first injection of the season, then run outside and soak up some of this amazing Northern California sunshine
including semaglutide branded as Wegovy or Ozempic, and tirzepatide (dual GIP/GLP-1 receptor agonist) branded as Zepbound or Mounjaro, for the management of obesity, type 2 diabetes, and other metabolic conditions increases, so too does the need to assess the advantages and potential downsides of long-term use
Progress tracked with patience
Researchers will monitor them for 24 weeks to track changes in drinking, health, and quality of life to determine whether the medication offers a meaningful new treatment option